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Abstract: The HERV-K(HML-2) family contains the most recently integrated and best 
preserved endogenized proviral sequences in the human genome. All known elements  
have nevertheless been subjected to mutations or deletions that render expressed particles  
non-infectious. Moreover, these post-insertional mutations hamper the analysis of the 
general biological properties of this ancient virus family. The expression of consensus 
sequences and sequences of elements with reverted post-insertional mutations has therefore 
been very instrumental in overcoming this limitation. We investigated the particle 
morphology of a recently reconstituted HERV-K113 element termed oriHERV-K113 using 
thin-section electron microscopy (EM) and could demonstrate that strong overexpression 
by substitution of the 5'LTR for a CMV promoter and partial codon optimization altered 
the virus assembly type and morphology. This included a conversion from the regular  
C-type to an A-type morphology with a mass of cytoplasmic immature cores tethered to 
the cell membrane and the membranes of vesicles. Overexpression permitted the release 
and maturation of virions but reduced the envelope content. A weaker boost of virus 
expression by Staufen-1 was not sufficient to induce these morphological alterations.  
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HERVs comprise over 8% of the human genome and there are more than 500,000 individual 
elements scattered throughout our chromosomes. These elements are derived from former exogenous 
retroviruses that infected germ cells or their progenitor cells and have since been vertically transferred 
from generation to generation [1]. HERVs are usually very ancient and are classified into different 
families. Indeed, members of some HERV families can be identified in Old World and New World 
monkeys at corresponding chromosomal loci, indicating that their integration occurred in an ancestral 
primate that lived at a point in time preceding the split between the groups over 35 million years  
ago [2,3]. 
The youngest (i.e., the most recently integrated) retroviral elements belong to the HERV-K(HML-2) 
family. As they use a lysine (K) tRNA to prime their reverse transcription and are related to the mouse 
mammary tumor virus (MMTV), these proviruses, together with nine other families, are termed 
HERV-K(HML). This relationship is reflected in the acronym HML, which stands for “human  
MMTV-like”. Elements of the HERV-K(HML-2) family are found exclusively in Old World primates 
including humans. Indeed, several members are specific to humans, suggesting integration after  
the separation of the human and chimpanzee lineages about five million years ago.  
During their residency in the host genome, endogenous retroviruses have been subjected to  
mutations and deletions. Purifying selection that keeps reading frames open has only been documented 
for a few HERV sequences [4]. The most recently integrated proviruses are therefore usually the best 
preserved. Currently, more than 90 well preserved HERV-K(HML-2) proviruses are known to be present 
in the human genome [5]. These elements still have open reading frames encoding functional  
viral proteins. Moreover, protein expression as well as assembly and release of non-infectious  
HERV-K(HML-2) particles has been observed in teratocarcinomas and melanomas and in cell lines 
derived therefrom [6,7]. Although not yet demonstrated, it cannot be excluded that some individuals 
alive today carry proviruses encoding infectious HERV-K(HML-2) elements or that infectious  
viruses might occasionally emerge through recombination between non-infectious elements [8]. Such 
recombination events reconstituting functional proviruses from inactivated endogenous elements 
would not be without precedence and have already been documented in animals [9,10]. A plethora  
of knowledge concerning the basic biology of HERV-K(HML2) and various aspects of the virus/host 
interaction has recently been obtained by expressing engineered consensus sequences and a 
reconstituted HERV-K113 element (oriHERV-K113) in which synonymous post-insertional mutations 
have been reverted [11–13].  
In this current study we generated and expressed a CMV-promoter driven and partially  
codon-optimized version of a reconstituted HERV-K113 molecular clone (oriHERV-K113) described 
previously [11]. In comparison to oriHERV-K113, high expression of the codon optimized variant 
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(termed oricoHERV-K113) lead to an unexpected switch from a C-type to an A-type-like morphology, 
as demonstrated by thin-section electron microscopy. 
2. Materials and Methods 
2.1. Plasmids 
The generation of pBSK-oriHERV-K113 (“oriHERV-K113”) has been described elsewhere [11]. 
Briefly, the proviral sequence of HERV-K113 (GenBank AY037928) was amplified from the  
RP11-12X BAC-library plasmid [14] and cloned into the pBlueskript SK+ (pBSK) vector (Agilent 
Technologies, Inc., Cedar Creek, NE, USA). 25 non-synonymous mutations and three mutations in the 
3'LTR were identified as postinsertional mutations by alignment with other HERV-K(HML-2) elements 
[11,15,16] and subsequently corrected by multi-site directed mutagenesis (QuikChange®, Agilent 
Technologies, Inc.). pcDNA-oricoHERV-K113 (“oricoHERV-K113”) consists of the oriHERV-K113 
genome with regions codon-optimized for enhanced protein expression in mammalian cells. The 
complete proviral oricoHERV-K113 genome sequence was synthesized (Geneart, Regensburg, 
Germany) and cloned behind the CMV promoter in pcDNA3.1 (Lifetechnologies, Carlsbad, CA, 
USA). Construction of the human Staufen-1 expression vector has been described previously [17]. 
2.2. Cell Culture 
HEK 293T and HeLa cells were cultured in complete Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% fetal bovine serum, L-glutamine (2 mM), penicillin (50 U/mL) and 
streptomycin (50 μg/mL).  
2.3. Virus Particle Purification and Preparation of Cell Lysates 
For electron microscopy analysis and Western blots, 2.4 × 106 or 5 × 105 HEK 293T or HeLa cells 
were seeded into 100 mm dishes or 6-well plates (TPP, Trasadingen, Switzerland), respectively and 
subsequently transfected with the plasmids using calcium phosphate or the Qiagen Polyfect Kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions. At two to four days post 
transfection, samples of culture media were harvested, clarified at 3345 × g for 8 min and filtered  
(0.45 μm) to remove cell debris. For samples derived from 100 mm dishes, supernatants were then 
centrifuged at 175,000 × g for 3 h at 4 °C through a 20% sucrose cushion in a Beckman SW32Ti rotor. 
Virus pellets were resuspended in 60 μL of 0.05 M Hepes buffer, pH 7.2 for Western blot analysis.  
To prepare cell lysates, transfected cells were resuspended in cell lysis buffer (1% Triton-X 100, 20 mM 
Tris pH 7.7, 150 mM NaCl) containing complete protease inhibitor cocktail (Roche Diagnostic, 
Mannheim, Germany). 
2.4. EM 
The procedure for preparing samples for electron microscopy has been published elsewhere [15].  
In short, at two days post-transfection, cells were fixed with 2.5% glutaraldehyde in 0.05 M Hepes  
(pH 7.2) for 1 h at room temperature before harvesting (scraping) and centrifugation at 2000 × g.  
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Cell pellets were post-fixed with OsO4 (1% in ddH2O; Plano, Wetzlar, Germany), block-stained with 
uranyl acetate (2% in ddH2O; Merck, Darmstadt, Germany), dehydrated stepwise in graded alcohol, 
immersed in propylenoxide and embedded in Epon (Serva, Heidelberg, Germany) with polymerisation 
at 60 °C for 48 h. Ultrathin sections (60–80 nm) were cut using an ultramicrotome (Ultracut S or UCT; 
Leica, Germany) and stained with 2% uranyl acetate and lead citrate. For post-embedding immunostaining, 
cells were fixed with 4% paraformaldehyde and 0.1% glutaraldehyde. They were dehydrated by graded 
alcohol and embedded in Lowicryl (HM20) according to the progressive lowering temperature 
technique. Thin sections applied to uncoated 300hexa Mesh nickel grids were incubated on droplets of 
blocking buffer (5% milk powder in PBS) for 30 min, and subsequently in blocking buffer with rat 
anti-CA, rat anti-p15 (both polyclonal sera were prepared in the lab of the authors) or goat anti-GFP 
(Rockland Immunochemicals for Research, Limerick, PA, USA) and a 5 nm gold-conjugated anti-rat/goat 
antibody (BB International, Cardiff, UK) for 1 h. After fixation with 0.1% glutaraldehyde in 0.05% 
Hepes buffer for 15min, samples were counterstained with 2% uranyl acetate and 0.2% lead citrate. 
Transmission electron microscopy was performed with an EM 902 (Zeiss) operating at 80 kV and the 
images were digitized using a slow-scan charge-coupled-device camera (Pro Scan, Scheuring, Germany). 
2.5. SDS PAGE and Western Blot Analysis 
Viral lysates or pelleted virus particles were mixed with 5× sample buffer and heated for 10 min  
at 98 °C before being subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis  
(SDS-PAGE). The proteins were transferred onto a PVDF membrane (Roth, Karlsruhe, Germany) by 
semi-dry electrophoresis (Biorad, München, Germany). After blocking in PBS with 5% skim milk 
powder and 0.1% Tween, the membranes were probed with specific rat anti-CA sera as described 
previously [15] and a secondary horseradish peroxidase-conjugated goat-anti-rat antibody (Sigma-Aldrich, 
Hamburg, Germany). The β-actin was detected with the HRP-conjugated AC-40 mouse monoclonal 
antibody (Sigma-Aldrich). Proteins were visualized using SuperSignal West Dura Chemiluminescent 
Substrate (Thermo Fisher Scientific Inc., Waltham, MA, USA) and Kodak Medical X-ray film. 
3. Results  
3.1. Generation of a Codon-Optimized Molecular Clone of a Reconstituted HERV-K(HML-2) Element 
We previously described 25 non-synonymous post-insertional mutations in the HERV-K113 
provirus originally characterised by Turner and co-workers [11,14–16]. Reversion of these 25 
mutations and the reversion of three presumed additional post-insertional mutations in the 3'LTR of a 
molecular clone (to yield a clone termed oriHERV-K113) allowed the expression of replication-
defective retroviral particles in transfected human cell lines [11].  
In order to boost the relatively low levels of particle expression, we also constructed a molecular 
clone in which parts of the oriHERV-K113 genome were codon-optimized, leaving potential 
regulatory sequences and regions of overlapping reading frames unchanged [15]. To further  
enhance expression, we replaced the viral 5'LTR with a CMV promoter and named the resulting  
near-full-length molecular clone “oricoHERV-K113” (Figure 1A).  
 





Figure 1. Genomic organization and expression of the reconstituted human endogenous 
retrovirus (HERV-K) human MMTV-like-2 HERV-K(HML-2) sequence “oriHERV-K113” 
and the partial codon-optimized variant with CMV promoter “oricoHERV-K113”. (A) For 
reconstitution of the potential infectious progenitor sequence of the HERV-K(HML-2) 
element, 25 non-synonymous putative post-insertional mutations (indicated by black 
arrows, lower arrow refers to rec reading frame) in the HERV-K113 genome sequence 
(AY037928) were reverted to generate oriHERV-K113. In oricoHERV-K113, parts of the 
oriHERV-K113 genome were codon-optimized (boxed in green) to achieve maximal 
expression in mammalian cells, leaving potential regulatory sequences or overlapping 
regions in the genome unaltered. The 5'LTR region was replaced by a CMV promoter 
(red). Numbers given for start and end of codon-optimized regions refer to genbank 
sequence AY037928. (B) Western blot of intracellular Gag proteins, processing fragments 
and degradation intermediates after transfection of the molecular clones in HEK 239T cells 
using a Gag (CA)-protein-specific antiserum for detection. Bands presumably representing 
the Gag-Pro, Gag and CA proteins are indicated. Stripping and re-probing of the membrane 
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with ß-Actin specific monoclonal antibody demonstrated that the same amounts of cell lysate 
were loaded for mock, oriHERV-K113 and oricoHERV-K113 transfected cells, respectively. 
Western blot analysis of transfected HEK 293T cells using a capsid-specific antiserum revealed that 
Gag expression from oricoHERV-K113 was at least 50-fold higher than that of oriHERV-K113 
(Figure 1B). 
3.2. Differences in the Morphologies of oriHERV-K113 and oricoHERV-K113  
We next set out to analyze the morphological impact of the modulated expression of retroviral 
proteins by thin-section EM analysis of human cell lines transfected with oricoHERV-K113. 
As previously reported [11], oriHERV-K113 produces particles with immature and condensed 
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Figure 2. Thin-section electron micrographs of oriHERV-K113 and oricoHERV-K113 
particle production after transfection with full-length molecular clones. (A) In HEK 293T 
cells, both immature oriHERV-K113 derived particles with ring-like structures of Gag 
proteins (marked by arrows) and mature forms with the condensed cores (marked by an 
arrowhead) are seen. (B) Env is incorporated strongly into the viral membrane (arrows). 
(C) Budding of oriHERV-K113 particles is of typical C-type morphology with the 
assembly of the Gag shells at the cellular membrane during budding (an arrow indicates a 
budding stage). (D) oriHERV-K113 particles produced in HeLa cells. (E,F) oricoHERV-K113 
transfected HEK 293T cells produce large numbers of particles that line up with the 
cellular membrane and display an A-type morphology, predominantly with preassembled 
rings of Gag protein attached to the membranes. (G) oricoHERV-K113 occasionally forms 
budding chains with structures resembling C-type morphology (arrows). (H) Incorporation 
of Env into the viral membrane of oricoHERV-K113 appears to be very low. Shown is a 
released mature particle produced by HeLa cells (I) Immunostaining EM with a CA 
specific antiserum. (J) Immunostaining EM with a p15-specific antiserum and a GFP 
control antiserum (K). (L) No transfection control.  
The overall production of viral particles is low, with only few budding stages or clusters of released 
immature and mature particles per cell. Cell sections with oriHERV-K113 virions were relatively rare. 
Only about one out of 20–30 cell sections contained particles. The budding morphology of oriHERV-K113 
is typically C-type, despite it being a betaretrovirus according to its pol region sequence [18]. The Gag 
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molecules commence assembly at the cell membrane in a convex formation that resembles in form the 
letter “C” (Figure 2C). We never observed a complete closure of the Gag ring during the late budding 
stages, indicating a virtually concomitant completion of the Gag shell and pinching off of the virion. 
There were also no immature virus-like particles present in the cytoplasm of cells transfected with 
oriHERV-K113. The results following transfection of the oriHERV-K113 full-length molecular clone 
into HeLa cells were similar to those with HEK 293T cells (Figure 2D).  
The picture is different in cells transfected with oricoHERV-K113. In these cells, particles with 
completely closed Gag shells line up at the inner leaflet of the plasma membrane (Figure 2E,F) and in 
some cells also at the cytoplasmic side of vesicular membranes. The cytoplasmic assembly of particles 
having completely closed immature cores is reminiscent of the regular retroviral A- and B-type 
morphology and is comparable to the mode of assembly of typical betaretroviruses including mouse 
MMTV and Mason Pfizer Monkey Virus (MPMV) [19]. Many of the transfected cells display budding 
chains in plasma membrane protrusions (Figure 2G). Although intracellular particles predominate, 
immature and mature virions are also present outside of the cells (Figure 2G,H), indicating some 
degree of particle release from the cell. The incorporation of Env in the viral membrane appears to be 
significantly lower compared to that in particles produced by oriHERV-K113, with very few spikes 
being present on budding structures or released particles (Figure 2G,H). Expressing oricoHERV-K113 
in HeLa cells results in morphologies similar to those observed in HEK 293T cells (Figure 2H).  
To confirm the identity of the oricoHERV-K(HML-2) particles we have performed immunostaining 
EM on thin-sections of transfected HEK 293T cells embedded in Lowicryl. Intra- and extracellular 
viral particles were specifically labelled with a CA and p15 specific antiserum, but not with an  
anti-GFP control (Figure 2I–K) No virus particles were observed in untransfected cells (Figure 2L). 
To further demonstrate virion release from cells transfected with oricoHERV-K113, the supernatant 
of transfected HEK 293T cells was pelleted by ultracentrifugation and embedded for thin-section EM. 
As shown in Figure 3, the pellets contain high proportions of exclusively mature virions with relatively 
large, typically concentric spherical or polygonal electron dense core structures against a background 
of contaminating microsomes (Figure 3). In agreement with the observations made in the previous 
experiment, spikes are barely visible on the surface of oricoHERV-K113 particles. Our data therefore 
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Figure 3. Virus particles in the supernatant of transfected HEK 293T cells. Cells were 
transfected with the full-length molecular clone oricoHERV-K113 and virions in the 
supernatant were pelleted by ultracentrifugation and embedded for thin-section EM. Nearly 
all particles show the condensed core of mature virions.  
3.3. Enhancement of oriHERV-K113 Expression by Staufen-1 Overexpression Does Not Result in a 
Morphology Switch from C- to A-Type 
We recently described the interaction of the HERV-K(HML-2) encoded proteins Rec and Gag with 
the human Staufen-1 protein and noticed a 20-fold increase in oriHERV-K113 production in cells 
overexpressing Staufen-1 [17].  
In order to boost oriHERV-K113 expression by Staufen-1 as strongly as possible and to evaluate  
a potential switch in morphology, we first optimized the transfection ratio of oriHERV-K113 and 
Staufen-1 expression plasmids. As shown in Figure 4, the peak of Gag expression is associated with  
an intermediate amount of Staufen-1 DNA; i.e., with a 4:1 ratio of oriHERV-K113 to Staufen-1 DNA.  
 
 
Figure 4. Co-expression of the human Staufen-1 protein enhances oriHERV-K113 protein 
production. Western blot detection by using a Gag (CA)-specific antiserum of intracellular 
HERV Gag protein 48 h after co-transfection of HEK 293T cells with a fixed amount of 
oriHERV-K113 full-length molecular clone and decreasing amounts of the Staufen-1 
expression vector. The presumed Gag-Pro, Gag and processed capsid proteins are 
indicated. The exposure time was optimized to show expression differences. It was too 
short to visualize Gag proteins on lane 6 (no Staufen-1 overexpression).  
The morphology of viral particles produced by transfected HEK 293T cells under optimized 
Staufen-1 mediated enhancement conditions were also analyzed by thin-section EM. Despite Staufen-1 
mediated enhancement resulting in significantly more viral particles, there was no evidence for a C- to 
A-type switch (Figure 5A, upper panel). However, even when enhanced by Staufen-1, the levels of 
Gag expression were still lower compared to that in cells transfected with oricoHERV-K113 (Figure 5B). 
As expected, co-transfection of Staufen-1 did not alter the morphology of oricoHERV-K113 particles 
(Figure 5A, lower panel) and had only a minimal enhancing effect on the expression of the 
oricoHERV-K113 Gag protein (Figure 5B), which is probably due to the high baseline level of protein 
expression from this construct. 
 





Figure 5. Thin-section EM of oriHERV-K113 and oricoHERV-K113 particle production 
after co-transfection of full-length molecular clones with Staufen-1 in a 4:1 ratio to 
enhance protein production. (A) Upper panel: EM of particles produced by oriHERV-K113 
after co-transfection with Staufen-1. No changes in C-type morphology can be seen despite 
enhancement of protein production by Staufen-1. Lower panel: Same experiment with 
oricoHERV-K113, no influence on the A-type morphology can be seen as a result of 
moderate Staufen-1 enhancement. (B) Western blot of Staufen-1-mediated enhanced Gag 
protein expression in HEK 293T cell lysate. Cells were transfected with oriHERV-K113 
and Staufen-1 (4:1 ratio), oricoHERV-K113, oricoHERV-K113 and Staufen-1 (4:1 ratio), 
Staufen-1 alone and with empty vector as mock control (left to right). Intracellular Gag 
was detected by Gag (CA)-protein specific antiserum. As loading control, the membrane 
was stripped and re-probed with a ß-Actin specific monoclonal antibody.  




Codon-optimization of retroviral sequences is commonly used to enhance protein expression in 
eukaryotic cells [20,21]. For the structural viral proteins, this is achieved in two main ways: First,  
it increases the efficiency of translation at the ribosome and, second, it releases transcripts from the 
nuclear restrictions involved in the control of nucleocytoplasmic transport of unspliced or partially 
spliced viral mRNAs. In an attempt to boost the expression of oriHERV-K113, a reconstituted  
HERV-K(HML-2) element, we codon-optimized large sections of the genes coding for Gag, Pro,  
Pol and Env. Regions containing the presumed packaging site, slippery sites, splice sites and the  
Rec-responsive element were left unchanged [15]. Additionally, the relatively weak 5'LTR promoter was 
substituted for the stronger CMV promoter. The resulting construct was termed “oricoHERV-K113”.  
Upon transfection into eukaryotic cells, a dramatic increase in the levels of cytoplasmic Gag was 
detected compared to those in cells transfected with oriHERV-K113. Interestingly, in oricoHERV-K113 
transfectants, thin-section electron microscopy revealed the presence of a multitude of cytoplasmic 
particles with apparently completely assembled Gag shells. Such intracellular particles with immature 
cores had never been seen in cells expressing oriHERV-K113, where only budding stages or released 
immature and mature virions were seen. This is consistent with earlier observations in teratocarcinoma 
cell lines [6,22] and with the documented morphologies of virions or virus like particles generated  
with HERV-K(HML-2) consensus sequences [12,13]. In these reports, particles budded at the cell 
membrane with a conventional C-type morphology [23,24] even if the transcription of the consensus 
sequences was driven by a CMV-promoter [12,13]. Based on these observations we speculate that the 
CMV-promoter alone would not be sufficient to cause formation of closed immature intracellular 
HERV-K113 cores. Whether this is true or whether codon optimization is already sufficient to induce 
intracellular particles needs to be resolved in experiments with appropriate vectors. Initially, 
retroviruses were classified according to their appearance and budding phenotype as visualized by  
EM [23,24] (reviewed by [25]). The C-type morphology is typically associated with oncoviruses and 
lentiviruses where formation of the immature core occurs concomitantly with budding at the cell 
membrane. In the case of B- and D-type retroviruses, the assembly of immature capsids occurs in  
the cytoplasm with subsequent transport to the cell membrane. Furthermore, completely assembled 
immature cytoplasmic cores of the prototype B-type retrovirus MMTV are designated as A-type 
particles [24]. Unusual groups in this respect are the intracisternal A-type particles of rodent cells that 
are encoded by endogenous elements and which assemble and bud into cisternae of the endoplasmic 
reticulum [26]. With respect to morphology, the highly abundant oricoHERV-K113 particles are best 
classified as A-type. The vast majority of the particles are tethered to the plasma membrane or to the 
membranes of vesicular structures. Budding chains are very frequently seen with incomplete immature 
cores, although regular budding stages are also occasionally observed. Taking these observations into 
account, we assume that the A-type particles of oricoHERV-K113 are assembled at membranes. 
Whether the assembly sites are confined to the plasma membrane or whether assembly also takes place 
at vesicular membranes remains unknown. The type A-particles clearly present on the outside of 
vesicles might be explained by passive transport during endocytotic processes. The low frequency of 
viral particles inside of these vesicles that are besieged by virions indicates that budding into the lumen 
does not occur or is very inefficient.  
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In contrast to the situation with vesicles, the release of oricoHERV-K113 virions into the supernatant 
is very efficient. Thin-section EM of virus pellets from supernatants of oricoHERV-K113 expressing 
cells reveals high numbers of particles. It is, however, currently unclear to which extent type  
A-particles are able to leave the cell or whether the pelleted particles were released by C-type budding 
occurring in parallel to the formation of A-type particles. Whatever the dominant budding phenotype, 
the particles released have mature cores. Efficient egress and maturation of oricoHERV-K113 has been 
confirmed by Western blotting and the measurement of RT activity in the supernatants (data not 
shown). These findings indicate that the partial codon-optimization of oriHERV-K113 does not 
prevent the switching of reading frames, the production of Gag-Pro and Gag-Pro-Pol precursor 
proteins or the release of active protease and reverse transcriptase. These results are consistent with 
those we obtained earlier by expressing the Gag-Pro-Pol region of oricoHERV-K113 alone [15].  
The use of a strong promoter and partial codon optimization of oricoHERV-K113 did not enhance 
expression of Env to the same degree seen for the Gag-polyproteins. As a consequence, spikes on 
oricoHERV-K113 particles are rarely observed. Whether the level of Env expression or the cellular 
Env to Gag ratio plays a role in the formation of HERV-K(HML-2) type A particles needs to be 
determined and is currently under investigation. 
Despite a significant boost, it was not possible to drive oriHERV-K113 into the production of  
type A-particles by overexpression of Staufen-1, a binding partner of the Rec protein [17]. However, 
the enhanced levels of Gag expression were still significantly lower than those seen with oricoHERV-K113 
alone. We therefore favor the hypothesis that a critical level of expression required for the production 
of HERV-K(HML-2)-derived type A-particles was not reached.  
Whether this type of particle is formed in vivo and whether they have a relevant biological role is 
also a matter of speculation. It is conceivable in this context that such cores might be potentially 
transferred from cell-to-cell or might play a role in retrotransposition events contributing to  
HERV-K(HML-2) proliferation following endogenization. Whatever the biological role and the 
underlying molecular mechanism of the morphological switch reported in this paper is, it is certain that 
EM will continue to play a pivotal role in future studies aimed at shedding light on this issues.  
Acknowledgments 
We would like to thank Gudrun Holland and Lars Möller for help with the electron microscopy  
and Stephen Norley for helpful discussions and advice. The work was supported in part by a donation 
from the Heinz Kuthe de Mouson legacy. 
Author Contributions 
OH performed the protein purification, immunization and characterization of the rat sera, carried 
out expression analysis and drafted the paper. VL and AZ performed electron microscopy, virus 
concentrations and RT activity assays. KH and SM carried out the Staufen interacting experiments.  
VL and NB reconstructed the original sequence of HERVK113 (oriHERV-K113) via sequence 
alignment and mutagenesis. NB conceived and coordinated the study. All authors read and approved 
the final manuscript.  
Viruses 2014, 6 4344 
 
 
Conflicts of Interest 
The authors declare no conflict of interest.  
References and Notes 
1. Weiss, R.A.; Stoye, J.P. Virology. Our viral inheritance. Science 2013, 340, 820–821. 
2. Bannert, N.; Kurth, R. The evolutionary dynamics of human endogenous retroviral families.  
Annu. Rev. Genom. Hum. Genet. 2006, 7, 149–173. 
3. Schrago, C.G. On the time scale of new world primate diversification. Am. Phys. Anthropol. 2007, 
132, 344–354. 
4. Mi, S.; Lee, X.; Li, X.; Veldman, G.M.; Finnerty, H.; Racie, L.; LaVallie, E.; Tang, X.Y.; 
Edouard, P.; Howes, S.; et al. Syncytin is a captive retroviral envelope protein involved in human 
placental morphogenesis. Nature 2000, 403, 785–789. 
5. Subramanian, R.P.; Wildschutte, J.H.; Russo, C.; Coffin, J.M. Identification, characterization, and 
comparative genomic distribution of the herv-k (hml-2) group of human endogenous retroviruses. 
Retrovirology 2011, 8, doi:10.1186/1742-4690-8-90. 
6. Bieda, K.; Hoffmann, A.; Boller, K. Phenotypic heterogeneity of human endogenous retrovirus 
particles produced by teratocarcinoma cell lines. J. Gen. Virol. 2001, 82, 591–596. 
7. Buscher, K.; Trefzer, U.; Hofmann, M.; Sterry, W.; Kurth, R.; Denner, J. Expression of human 
endogenous retrovirus k in melanomas and melanoma cell lines. Cancer Res. 2005, 65, 4172–4180. 
8. Stoye, J.P. Endogenous retroviruses: Still active after all these years? Curr. Biol. 2001, 11,  
R914–R916. 
9. Young, G.R.; Eksmond, U.; Salcedo, R.; Alexopoulou, L.; Stoye, J.P.; Kassiotis, G. Resurrection 
of endogenous retroviruses in antibody-deficient mice. Nature 2012, 491, 774–778. 
10. Yu, P.; Lubben, W.; Slomka, H.; Gebler, J.; Konert, M.; Cai, C.; Neubrandt, L.; Prazeres da Costa, O.; 
Paul, S.; Dehnert, S.; et al. Nucleic acid-sensing toll-like receptors are essential for the control of 
endogenous retrovirus viremia and erv-induced tumors. Immunity 2012, 37, 867–879. 
11. Chudak, C.; Beimforde, N.; George, M.; Zimmermann, A.; Lausch, V.; Hanke, K.; Bannert, N. 
Identification of late assembly domains of the human endogenous retrovirus-k(hml-2). 
Retrovirology 2013, 10, doi:10.1186/1742-4690-10-140. 
12. Dewannieux, M.; Harper, F.; Richaud, A.; Letzelter, C.; Ribet, D.; Pierron, G.; Heidmann, T. 
Identification of an infectious progenitor for the multiple-copy herv-k human endogenous 
retroelements. Genome Res. 2006, 16, 1548–1556. 
13. Lee, Y.N.; Bieniasz, P.D. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog. 
2007, 3, e10. 
14. Turner, G.; Barbulescu, M.; Su, M.; Jensen-Seaman, M.I.; Kidd, K.K.; Lenz, J. Insertional 
polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 2001, 11, 1531–1535. 
15. George, M.; Schwecke, T.; Beimforde, N.; Hohn, O.; Chudak, C.; Zimmermann, A.; Kurth, R.; 
Naumann, D.; Bannert, N. Identification of the protease cleavage sites in a reconstituted gag 
polyprotein of an herv-k(hml-2) element. Retrovirology 2011, 8, doi:10.1186/1742-4690-8-30. 
Viruses 2014, 6 4345 
 
 
16. Hanke, K.; Kramer, P.; Seeher, S.; Beimforde, N.; Kurth, R.; Bannert, N. Reconstitution of  
the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional 
activity by truncation of the cytoplasmic domain. J. Virol. 2009, 83, 12790–12800. 
17. Hanke, K.; Hohn, O.; Liedgens, L.; Fiddeke, K.; Wamara, J.; Kurth, R.; Bannert, N. Staufen-1 
interacts with the human endogenous retrovirus family herv-k(hml-2) rec and gag proteins and 
increases virion production. J. Virol. 2013, 87, 11019–11030. 
18. Andersson, M.L.; Lindeskog, M.; Medstrand, P.; Westley, B.; May, F.; Blomberg, J. Diversity of 
human endogenous retrovirus class ii-like sequences. J. Gen. Virol. 1999, 80, 255–260. 
19. Fine, D.; Schochetman, G. Type d primate retroviruses: A review. Cancer Res. 1978, 38, 3123–3139. 
20. Deml, L.; Bojak, A.; Steck, S.; Graf, M.; Wild, J.; Schirmbeck, R.; Wolf, H.; Wagner, R. Multiple 
effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines 
encoding the human immunodeficiency virus type 1 gag protein. J. Virol. 2001, 75, 10991–11001. 
21. Wagner, R.; Graf, M.; Bieler, K.; Wolf, H.; Grunwald, T.; Foley, P.; Uberla, K. Rev-independent 
expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian 
immunodeficiency virus: Implications for the safety of lentiviral vectors. Hum. Gene Ther. 2000, 
11, 2403–2413. 
22. Boller, K.; Frank, H.; Lower, J.; Lower, R.; Kurth, R. Structural organization of unique  
retrovirus-like particles budding from human teratocarcinoma cell lines. J. Gen. Virol. 1983, 64, 
2549–2559. 
23. Bernhard, W. The detection and study of tumor viruses with the electron microscope. Cancer Res. 
1960, 20, 712–727. 
24. Gelderblom, H.R.; Özel, M.; Gheysen, D.; Reupke, H.; Winkel, T.; Herz, U.; Grund, C.; Pauli, G. 
Morphogenesis and Fine Structure of Lentiviruses; Elsevier Science Ltd: München, Germany, 
1990. 
25. Nermut, M.V.; Hockley, D.J. Comparative morphology and structural classification of retroviruses. 
Curr. Top. Microbiol. Immunol. 1996, 214, 1–24. 
26. Kuff, E.L.; Lueders, K.K. The intracisternal a-particle gene family: Structure and functional 
aspects. Adv. Cancer Res. 1988, 51, 183–276. 
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
